Log In
BCIQ
Print this Print this
 

PTG-100

  Manage Alerts
Collapse Summary General Information
Company Protagonist Therapeutics Inc.
DescriptionIntegrin alpha(4)beta(7) peptide antagonist
Molecular Target Integrin alpha(4)beta(7)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase I
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat inflammatory bowel diseases (IBD); Treat moderate-to-severe ulcerative colitis (UC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today